HPR6 Inflation Reduction Act: How Will the First 10 Drugs Selected for Medicare Price Negotiations Impact US Commercial Payers?

Abstract

Authors

C Sidhu B Connelly M Waththuhewa N Sullivan

Full Text Cite This Article
Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×